Pat Granahan and Chelsea Loughran quoted on CRISPR-Cas in Nature Biotechnology

The July issue of Nature Biotechnology quotes Pat Granahan and Chelsea Loughran on the first CRISPR-Cas patent and the race to stake out intellectual property in this area. Read more (subscription required).